Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
AstraZeneca's two FDA approvals
Health

AstraZeneca Secures 2 FDA Approvals in Bladder Cancer, Myasthenia Gravis

November 17, 2026 Evan Vega

AstraZeneca wins FDA approvals for Imfinzi-Padcev in bladder cancer and KLYGEFA in myasthenia gravis.

Light-Sound May Slow Alzheimer's
Health

Device That Uses Light and Sound May Slow Alzheimer’s Symptoms in Some Patients

November 17, 2026 Evan Vega
Health

Servier presents four-year results from Phase 2 FIREFLY-1 study of OJEMDA in pediatric low-grade glioma at SNO 2026

November 16, 2026 Evan Vega
US loses measles elimination
Health

US loses measles elimination status after 26 years as historic resurgence sickens thousands

November 15, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega
AstraZeneca's two FDA approvals
Health

AstraZeneca Secures 2 FDA Approvals in Bladder Cancer, Myasthenia Gravis

November 17, 2026 Evan Vega

AstraZeneca wins FDA approvals for Imfinzi-Padcev in bladder cancer and KLYGEFA in myasthenia gravis.

Light-Sound May Slow Alzheimer's
Health

Device That Uses Light and Sound May Slow Alzheimer’s Symptoms in Some Patients

November 17, 2026 Evan Vega
Health

Servier presents four-year results from Phase 2 FIREFLY-1 study of OJEMDA in pediatric low-grade glioma at SNO 2026

November 16, 2026 Evan Vega
US loses measles elimination
Health

US loses measles elimination status after 26 years as historic resurgence sickens thousands

November 15, 2026 Evan Vega
AstraZeneca's two FDA approvals
Health

AstraZeneca Secures 2 FDA Approvals in Bladder Cancer, Myasthenia Gravis

November 17, 2026 Evan Vega

AstraZeneca wins FDA approvals for Imfinzi-Padcev in bladder cancer and KLYGEFA in myasthenia gravis.

Light-Sound May Slow Alzheimer's
Health

Device That Uses Light and Sound May Slow Alzheimer’s Symptoms in Some Patients

November 17, 2026 Evan Vega
Health

Servier presents four-year results from Phase 2 FIREFLY-1 study of OJEMDA in pediatric low-grade glioma at SNO 2026

November 16, 2026 Evan Vega
US loses measles elimination
Health

US loses measles elimination status after 26 years as historic resurgence sickens thousands

November 15, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega
AstraZeneca's two FDA approvals
Health

AstraZeneca Secures 2 FDA Approvals in Bladder Cancer, Myasthenia Gravis

November 17, 2026 Evan Vega

AstraZeneca wins FDA approvals for Imfinzi-Padcev in bladder cancer and KLYGEFA in myasthenia gravis.

Light-Sound May Slow Alzheimer's
Health

Device That Uses Light and Sound May Slow Alzheimer’s Symptoms in Some Patients

November 17, 2026 Evan Vega
Health

Servier presents four-year results from Phase 2 FIREFLY-1 study of OJEMDA in pediatric low-grade glioma at SNO 2026

November 16, 2026 Evan Vega
US loses measles elimination
Health

US loses measles elimination status after 26 years as historic resurgence sickens thousands

November 15, 2026 Evan Vega
AstraZeneca's two FDA approvals
Health

AstraZeneca Secures 2 FDA Approvals in Bladder Cancer, Myasthenia Gravis

November 17, 2026 Evan Vega

AstraZeneca wins FDA approvals for Imfinzi-Padcev in bladder cancer and KLYGEFA in myasthenia gravis.

Light-Sound May Slow Alzheimer's
Health

Device That Uses Light and Sound May Slow Alzheimer’s Symptoms in Some Patients

November 17, 2026 Evan Vega
Health

Servier presents four-year results from Phase 2 FIREFLY-1 study of OJEMDA in pediatric low-grade glioma at SNO 2026

November 16, 2026 Evan Vega
US loses measles elimination
Health

US loses measles elimination status after 26 years as historic resurgence sickens thousands

November 15, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega
AstraZeneca's two FDA approvals
Health
November 17, 2026 Evan Vega

AstraZeneca Secures 2 FDA Approvals in Bladder Cancer, Myasthenia Gravis

AstraZeneca wins FDA approvals for Imfinzi-Padcev in bladder cancer and KLYGEFA in myasthenia gravis.

Read More
Light-Sound May Slow Alzheimer's
Health
November 17, 2026 Evan Vega

Device That Uses Light and Sound May Slow Alzheimer’s Symptoms in Some Patients

Experimental light-and-sound device slowed cognitive decline in mild Alzheimer’s patients, trial shows.

Read More
Health
November 16, 2026 Evan Vega

Servier presents four-year results from Phase 2 FIREFLY-1 study of OJEMDA in pediatric low-grade glioma at SNO 2026

Servier presents four-year FIREFLY-1 data: OJEMDA shows 50.9-month median time to next treatment in pediatric low-grade glioma.

Read More
US loses measles elimination
Health
November 15, 2026 Evan Vega

US loses measles elimination status after 26 years as historic resurgence sickens thousands

US loses measles elimination status after 26 years; PAHO cites 12-month transmission and 5,400+ cases in 2026.

Read More
Measles cases top 5,000
Health
November 9, 2026 Evan Vega

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Read More
Lp(a) reduction, neutral outcome
Health
November 8, 2026 Evan Vega

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

Lp(a) reduced 78% with pelacarsen, but cardiovascular outcomes showed no benefit in HORIZON trial.

Read More
Infant bleeding episodes jump
Health
November 8, 2026 Evan Vega

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

U.S. infant bleeding episodes rise as vitamin K shot refusals grow; rate fell from 97.7% to 95% (2017-2025) amid declining trust.

Read More
Amivantamab approved for HNSCC
Health
November 7, 2026 Evan Vega

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

FDA grants accelerated approval to amivantamab/hyaluronidase for recurrent/metastatic HNSCC after platinum and PD-1/PD-L1 therapy, based on 42% ORR.

Read More
FDA approves Rybrevant Faspro
Health
November 7, 2026 Evan Vega

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

FDA grants accelerated approval to Rybrevant Faspro for adults with recurrent or metastatic head and neck squamous cell carcinoma.

Read More
FDA Approves Pirtobrutinib Treatment
Health
October 4, 2026 Evan Vega

FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.

Read More
  • ← Previous
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.